Niacinamide

Niacinamide

SCHEMBL580103

NC(=O)c1cccnc1.O=C(O)CC(O)(C(=O)O)C(O)C(=O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.55
F3 P13726 1/20 0.55
SARM1 Q6SZW1 1/20 0.55
SIRT2 Q8IXJ6 1/20 0.55
SIRT6 Q8N6T7 1/20 0.55
SIRT1 Q96EB6 1/20 0.55
SIRT3 Q9NTG7 1/20 0.55
SIRT5 Q9NXA8 1/20 0.55
SIRT4 Q9Y6E7 1/20 0.55
CPT2 P23786 1/20 0.53
ACLY P53396 1/20 0.53
ALDH1A1 P00352 1/20 0.42
APP P05067 1/20 0.42
GAA P10253 1/20 0.42
HCAR3 P49019 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42
PLOD2 O00469 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Niacin SCHEMBL811549 0.90 ALDH1A1 (0.55) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL6918787 0.87 F7 (0.44) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL31098926 0.84 F7 (0.51) F7F3SARM1SIRT2SIRT6
Citric Acid SCHEMBL5352836 0.81 F7 (0.65) F7F3SARM1SIRT2SIRT6
SCHEMBL21247055 0.78 ALDH1A1 (0.45) F7F3SARM1SIRT2SIRT6
Niacin SCHEMBL5465552 0.77 ALDH1A1 (0.49) CPT2ACLYALDH1A1APPGAA
Cadaverine Tartrate SCHEMBL29103712 0.76 F7 (0.76) F7F3SARM1SIRT2SIRT6
Cadaverine Tartrate SCHEMBL27679158 0.76 F7 (0.76) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL580180 0.76 F7 (0.65) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL29011862 0.76 F7 (0.65) F7F3SARM1SIRT2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070031526-A1 Topical Deodorant Compositions Based on Hydroxycitric Acid BIODERM RESEARCH (US) 2007-02-08 US claimed
US-20040156873-A1 Topically Bioavailable Acne and Rosacea Treatment Compositions GUPTA SHYAM K (US) 2004-08-12 US claimed
US-20040081672-A1 Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging GUPTA SHYAM K (US) 2004-04-29 US claimed
CN-118302145-A Cosmetic water-in-oil emulsion comprising a specific water-soluble UV screening agent, a base, a volatile oil, a hydrophobic film-forming polymer, a polyoxyalkylene-alkylated linear polydimethylsiloxane and vitamin B3 莱雅公司 2024-07-05 CN disclosed
WO-2024133260-A1 PULMONARY DELIVERY DEVICES TWENTY SIXTEEN (2016) PHARMA LIMITED (GB) 2024-06-27 WO disclosed
EP-4370092-A2 A NON-THERAPEUTIC COSMETIC METHOD FOR REDUCING WRINKLES ON A SKIN SURFACE L'OREAL (FR) 2024-05-22 EP disclosed
US-20240100265-A1 PULMONARY DELIVERY DEVICES TWENTY SIXTEEN (2016) PHARMA LIMITED (GB) 2024-03-28 US disclosed
CN-117355289-A Non-therapeutic cosmetic method for reducing wrinkles on the surface of the skin 莱雅公司 2024-01-05 CN disclosed
US-20230405243-A1 PULMONARY DELIVERY DEVICES TWENTY SIXTEEN 2016 PHARMA LTD (GB) 2023-12-21 US disclosed
WO-2023119230-A1 COAGULATION PATHWAY AND NICOTINAMIDE-ADENINE DINUCLEOTIDE PATHWAY MODULATING COMPOSITIONS AND METHODS OF THEIR USE L'OREAL (FR) 2023-06-29 WO disclosed
WO-2023094277-A1 COSMETIC WATER-IN-OIL EMULSION COMPRISING A SPECIFIC WATER-SOLUBLE UV SCREENING AGENT, A BASE, A VOLATILE OIL, A HYDROPHOBIC FILM-FORMING POLYMER, A POLYOXYALKYLENATED LINEAR POLYDIMETHYLMETHYLSILOXANE AND A VITAMIN B3 L'OREAL (FR) 2023-06-01 WO disclosed
US-20060147508-A1 Concurrent Enhancement of Skin Penetration of Organic Base Active Agents and Organic Hydroxy Acid Active Agents as Their Ion-Pair Complexes BIODERM RESEARCH (US) 2006-07-06 US disclosed
US-20060110415-A1 Topical Delivery System for Cosmetic and Pharmaceutical Agents BIODERM RESEARCH (US) 2006-05-25 US disclosed
US-20060074108-A1 Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition BIODERM RESEARCH (US) 2006-04-06 US disclosed
WO-2006023710-A2 COSMETIC OR PHARMACEUTICAL COMPOSITION FOR SKIN CARE INFINITY2 HEALTH SCIENCES, INC. (US) 2006-03-02 WO disclosed
US-20060039887-A1 Cosmetic or pharmaceutical composition for skin care INFINITY2 HEALTH SCIENCES, INC. 2006-02-23 US disclosed
WO-2005123101-A1 BLACKBERRY EXTRACT SYMRISE GMBH & CO. KG (DE) 2005-12-29 WO disclosed
US-20040228884-A1 Ion-pair delivery system for cosmetic and pharmaceutical compositions GUPTA SHYAM K (US) 2004-11-18 US disclosed
US-20040185069-A1 Hydroxycitric acid derivatives for body slimming and tone firming compositions GUPTA SHYAM K (US) 2004-09-23 US disclosed
US-20040081672-A1 Niacinamide, niacin, and niacin esters based delivery systems for treating topical disorders of skin and skin aging GUPTA SHYAM K (US) 2004-04-29 US disclosed